Current use of biologicals for the treatment of spondyloarthropathies

Expert Opinion on Pharmacotherapy
F D KeyserE M Veys

Abstract

Spondyloarthropathies (SpA) are a group of related disorders. The hallmark symptoms include spondylitis, pauci-articular synovitis and enthesiopathy. In an important number of cases, subclinical gut inflammation with pathological findings resembling Crohn's disease can be found. Some of these patients may eventually develop overt Crohn's disease. Conventional medical therapy in patients with SpA consists of non-steroidal anti-inflammatory drugs (NSAIDs). Sulphasalazin can be co-administered, especially in cases of chronic synovitis or enthesiopathy. Recently, experience with anti-TNF-alpha monoclonal antibodies (infliximab), a new class of biological compounds, has opened new avenues for treating patients with SpA. In particular, infliximab used in two open studies gave significant benefit on the locomotor manifestations in patients with Crohn's disease, in patients with ankylosing spondylitis, undifferentiated SpA and psoriatic arthritis. Etanercept, another TNF-alpha antagonist (soluble receptor), was shown to induce benefit in a placebo-controlled study in patients with psoriatic arthritis. The relationship between SpA and inflammatory bowel disease lead to the hypothesis that interfering with gut inflammation in patients wi...Continue Reading

References

Jan 1, 1990·Scandinavian Journal of Rheumatology·A VerstraetenJ Dequeker
Jan 1, 1989·Rheumatology International·J P Hauzeur, T Appelboom
Jul 1, 1988·Annals of the Rheumatic Diseases·T L Vischer
Jul 1, 1993·The Journal of Clinical Investigation·D K PodolskyM deBeaumont
Aug 1, 1993·British Journal of Rheumatology·H R Müller-Fassbender
Apr 1, 1996·Digestive Diseases and Sciences·I Kirman, O H Nielsen
Mar 7, 1998·Clinical Immunology and Immunopathology·C N BernsteinW M Gallatin
Aug 26, 1998·Scandinavian Journal of Gastroenterology·T A GroolS J van Deventer
Jan 19, 1999·Rheumatic Diseases Clinics of North America·F De KeyserE M Veys
Jun 1, 1999·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·I CelikK J Klose
Aug 1, 2000·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·J S Cohen

❮ Previous
Next ❯

Citations

Aug 17, 2004·Rheumatology International·Ilana KaufmanOri Elkayam
Jan 29, 2008·Journal of Pediatric Gastroenterology and Nutrition·Folashade A Jose, Melvin B Heyman
Aug 1, 2008·Arthritis and Rheumatism·Jörg H W DistlerOliver Distler
Jul 15, 2015·Inflammatory Bowel Diseases·Stephan R VavrickaGerhard Rogler
Nov 3, 2010·The Journal of Rheumatology·Veerapong PhumethumSindhu R Johnson
Jan 5, 2002·American Journal of Clinical Dermatology·C G Jackson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Related Papers

Gastrointestinal Endoscopy
Michael Gluck, Allan Kayne
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete
J ElsnerJ Weiss
Expert Opinion on Investigational Drugs
E Toussirot, D Wendling
© 2021 Meta ULC. All rights reserved